Pneumococcal coinfection with human metapneumovirus

Journal of Infectious Diseases

Volumn 193, Issue 9, 2006, Pages 1236-1243

  Madhi, Shabir A ^a,c   Ludewick, Herbert ^a   Kuwanda, Locadiah ^a   Van Niekerk, Nadia ^a   Cutland, Clare ^a   Little, Tessa ^a   Klugman, Keith P ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PLACEBO; PNEUMOCOCCUS VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN METAPNEUMOVIRUS; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS INFECTION; VIRUS IDENTIFICATION;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, VIRAL; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 33646063844     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/503053     Document Type: Article

References (25)

1. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719-24.
2. Boivin G, Abed Y, Pelletier G, et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002; 186:1330-4.
3. Dollner H, Risnes K, Radtke A, Nordbo SA. Outbreak of human metapneumovirus infection in Norwegian children. Pediatr Infect Dis J 2004; 23:436-40.
4. Nissen MD, Siebert DJ, Mackay IM, Sloots TP, Withers SJ. Evidence of human metapneumovirus in Australian children. Med J Aust 2002; 176:188.
5. Madhi SA, Ludewick H, Abed Y, Klugman KP, Boivin G. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis 2003; 37:1705-10.
6. Chan PK, Tam JS, Lam CW, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1058-63.
7. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004; 350:443-50.
8. Cuevas LE, Nasser AM, Dove W, Gurgel RQ, Greensill J, Hart CA. Human metapneumovirus and respiratory syncytial virus, Brazil. Emerg Infect Dis 2003; 9:1626-8.
9. McIntosh K, McAdam AJ. Human metapneumovirus-an important new respiratory virus. N Engl J Med 2004; 350:431-3.
10. MacPhail M, Schickli JH, Tang RS, et al. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 2004; 85:1655-63.
11. Hamelin ME, Abed Y, Boivin G. Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis 2004; 38:983-90.
12. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003; 9:372-5.
13. Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811-3.
14. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
15. Madhi SA, Kuwanda L, Cutland C, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 2005; 40:1511-8.
16. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005; 83:353-9.
17. World Health Organization. Acute respiratory tract infections in children: case management in small hospitals in developing countries. WHO/ARI/90.5. Geneva: World Health Organization, 1994.
18. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999; 26:189-95.
19. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701-7.
20. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000; 19:293-8.
21. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19:187-95.
22. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206-17.
23. Madhi SA, Heera JR, Kuwanda L, Klugman KP. Use of procalcitonin and c-reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med 2005; 2:e38.
24. Banya WA, O'Dempsey TJ, Mcardle T, Lloyd-Evans N, Greenwood BM. Predictors for a positive blood culture in African children with pneumonia. Pediatr Infect Dis J 1996; 15:292-7.
25. Jartti T, Lehtinen P, Vuorinen T, et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 2004; 10:1095-101.